T60K (p.Thr60Lys) variant of ATXN3 (Ataxin-3)

T60K (p.Thr60Lys) in ATXN3 (Ataxin-3) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes population frequency data.

T60K (p.Thr60Lys) variant details